Insights

Market Positioning Target healthcare institutions and implantable neurotechnology developers who require scalable, cutting-edge medical device solutions, leveraging Synchron's focus on solving unmet medical needs at scale to open partnerships with hospitals and research centers.

Technology Leverage Highlight Synchron’s use of advanced tech stacks such as PyTorch and Verilog to appeal to research teams and integrators seeking proven software and hardware ecosystems, enabling collaborations on neural interfaces, data analytics, and boundary-pushing neuromodulation projects.

Strategic Partnerships Explore co-development or pilot programs with academic hospitals and specialized medical device manufacturers to accelerate adoption, co-funding opportunities, and regulatory pathway support for implantable neurotechnology.

Investment Signals Monitor and engage with investor activity around Synchrony Financial style indexing for potential financial partners or health tech investment groups that value long-term capital returns and stable credit, indicating readiness to fund joint ventures or commercial scale-up.

Regional Expansion Identify geographic markets and regulatory environments favorable to implantable neurotech deployment, pursuing joint ventures or distribution agreements in regions with supportive healthcare infrastructure and reimbursement pathways.

Synchron Tech Stack

Synchron uses 8 technology products and services including HashiCorp Terraform, Mimecast Secure Email Gateway, PyTorch, and more. Explore Synchron's tech stack below.

  • HashiCorp Terraform
    Configuration Management
  • Mimecast Secure Email Gateway
    Email Security
  • PyTorch
    Machine Learning
  • Microsoft
    Miscellaneous
  • Swift
    Programming Languages
  • Verilog
    Programming Languages
  • Piwik PRO Core
    Web Analytics
  • GoDaddy
    Web Hosting

Media & News

Synchron's Email Address Formats

Synchron uses at least 1 format(s):
Synchron Email FormatsExamplePercentage
FLast@synchron.comJDoe@synchron.com
98%
First@synchron.comJohn@synchron.com
2%

Frequently Asked Questions

What is Synchron's stock symbol?

Minus sign iconPlus sign icon
Synchron is a publicly traded company; the company's stock symbol is SYF.

What is Synchron's official website and social media links?

Minus sign iconPlus sign icon
Synchron's official website is synchron.com and has social profiles on LinkedIn.

What is Synchron's NAICS code?

Minus sign iconPlus sign icon
Synchron's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Synchron have currently?

Minus sign iconPlus sign icon
As of July 2026, Synchron has approximately 128 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Personal Assistant To Tom Oxley (ceo) And Omid Forouzan (vp, Clinical And Medical Affairs, New York: J. K.Owner: M. T.Director Strategic Marketing: C. B.. Explore Synchron's employee directory with LeadIQ.

What industry does Synchron belong to?

Minus sign iconPlus sign icon
Synchron operates in the Medical Equipment Manufacturing industry.

What technology does Synchron use?

Minus sign iconPlus sign icon
Synchron's tech stack includes HashiCorp TerraformMimecast Secure Email GatewayPyTorchMicrosoftSwiftVerilogPiwik PRO CoreGoDaddy.

What is Synchron's email format?

Minus sign iconPlus sign icon
Synchron's email format typically follows the pattern of FLast@synchron.com. Find more Synchron email formats with LeadIQ.

How much funding has Synchron raised to date?

Minus sign iconPlus sign icon
As of July 2026, Synchron has raised $330M in funding. The last funding round occurred on Nov 06, 2025.

When was Synchron founded?

Minus sign iconPlus sign icon
Synchron was founded in 2016.
Synchron logo

Synchron

Medical Equipment ManufacturingNew York, United States51-200 Employees

Synchron is a Brooklyn, New York-based medical equipment manufacturer developing implantable neurotechnology to unlock brain function and address unmet medical needs at scale. The company operates with 51 to 200 employees and maintains a website at synchron.com. Its work centers on brain-computer interface technology, with 2025 reports noting collaborations with Apple to develop devices—including iPhones—that could be controlled via neural signals. At NVIDIA's GTC 2025 conference, Synchron announced Chiral, a foundation model of human cognition trained directly on neural data. As of March 2025, the company indicated that a second generation of its technology would be ready by the end of the year.

Section iconCompany Overview

Stock Symbol
SYF
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $330M

    Synchron has raised a total of $330M of funding over 6 rounds. Their latest funding round was raised on Nov 06, 2025as a series_d.

  • $25M$50M

    Synchron's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $330M

    Synchron has raised a total of $330M of funding over 6 rounds. Their latest funding round was raised on Nov 06, 2025as a series_d.

  • $25M$50M

    Synchron's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.